's benefits and risks based on age and gender." Reuters says the suspension "affects both versions of the vaccine approved in Canada: One granted to AstraZeneca Canada, and a second for the Serum Institute of India (5II) — which is manufacturing its own version of the vaccine under license — and its Canadian partn